Lexicon Pharmaceuticals (LXRX) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.18
-0.14
-0.11
-0.07

Details

Expected EPS
-0.095
Actual EPS
-0.07
Surprise EPS
0.02
Surprise Percent
+26.32%

Description

Lexicon Pharmaceuticals (LXRX) has reported earnings of -0.07 per share for Q2 2025.

0 Comments

Share your thoughts